Asparaginase unveils glutamine-addicted AML

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia

(2013) L. Willems et al.   BLOOD

Adipocytes Cause Leukemia Cell Resistance to L-Asparaginase via Release of Glutamine

(2013) E. A. Ehsanipour et al.   CANCER RESEARCH

Glutamine and cancer: cell biology, physiology, and clinical opportunities

(2013) Christopher T. Hensley et al.   JOURNAL OF CLINICAL INVESTIGATION

Sequential administration of methotrexate and asparaginase in relapsed or refractory pediatric acute myeloid leukemia

(2013) Jassada Buaboonnam et al.   PEDIATRIC BLOOD & CANCER

l-Asparaginase as Potent Anti-leukemic Agent and Its Significance of Having Reduced Glutaminase Side Activity for Better treatment of Acute Lymphoblastic Leukaemia

(2012) L. N. Ramya et al.   APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY

Augmented Hyper-CVAD Based on Dose-Intensified Vincristine, Dexamethasone, and Asparaginase in Adult Acute Lymphoblastic Leukemia Salvage Therapy

(2012) Stefan Faderl et al.   Clinical Lymphoma Myeloma & Leukemia

Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy

(2009) Paul Nicklin et al.   CELL